影像学表现不确定的小软组织肿块:一家三级骨科肿瘤门诊的组织学诊断
该研究回顾性复习了一家三级骨科肿瘤门诊4.75年间42例最大径≤2 cm、影像学表现不确定的躯干/四肢软组织肿块,平均最大径1.5 cm,其中9例(21%)为恶性,39例(93%)位于浅表,浅表肿瘤中7/39(18%)为恶性。恶性与非恶性组的肿瘤:肌肉强化比及强化变异系数均无显著差异(p=0.58、p=0.29)。作者结论认为,此类小且表浅但影像学表现不确定的原发软组织肿块应谨慎处理。
要点
- ≤2 cm影像学表现不确定的软组织肿块中21%(9/42)为恶性,不可因体积小或位置表浅而放松警惕。
- 浅表肿块中18%(7/39)为恶性,恶性与是否毗邻血管、肌腱或筋膜无显著关联(p=0.19)。
- 肿瘤:肌肉强化比在非恶性组为2.15、恶性组为2.32(p=0.58),强化变异系数分别为0.14与0.10(p=0.29),均无显著差异。
核心结论
- 在三级骨科肿瘤转诊门诊中,最大径≤2 cm且影像学表现不确定的原发软组织肿块即使体积小和/或位置表浅,也应谨慎处理。
研究设计与样本
- IRB批准的回顾性研究,纳入连续4.75年间转诊至三级骨科肿瘤门诊的躯干/四肢软组织肿块患者,最大径≤2 cm,由接受肌骨影像专科培训的放射科医生在影像上测量最大径;排除单纯脂肪瘤、滑液囊肿、转移瘤及无组织学确认的病例;共42例,记录人口学、肿瘤影像特征(位置、深度、大小、肿瘤:肌肉强化比与T2信号比)及组织学并进行比较。
关键影像表现/征象
- 42例躯干/四肢软组织肿块平均最大径1.5 cm(范围0.7至2 cm),平均年龄48岁(范围18至83岁)。
- 9例(21%)为恶性,33例(79%)为非恶性;39例(93%)位于浅表,其中7/39(18%)为恶性。
- 恶性与是否毗邻血管、肌腱或筋膜无显著关联(p=0.19)。
- 非恶性组与恶性组的肿瘤:肌肉强化比分别为2.15与2.32(p=0.58),强化变异系数分别为0.14与0.10(p=0.29)。
诊断标准与关键数值
- 肿块最大径以影像测量为准,纳入标准为≤2 cm。
- 最常见恶性组织学亚型为滑膜肉瘤(n=3)、成纤维细胞性/肌纤维母细胞性肉瘤(n=2)、平滑肌肉瘤(n=2)、黏液纤维肉瘤(n=1)及血管瘤样纤维组织细胞瘤(n=1)。
- 多数(67%)非恶性病变为平滑肌瘤(n=6)、血管肌瘤(n=5)、神经鞘瘤(n=4)、良性纤维组织细胞瘤(n=4)及血管瘤(n=3)。
临床应用与阅片要点
- 对≤2 cm且影像学表现不确定的软组织肿块,应结合组织学诊断评估,不能仅凭体积小或位置表浅判断为良性。
- 肿瘤:肌肉强化比与强化变异系数在恶性与非恶性组间无显著差异,不能据此鉴别良恶性。
- 恶性与是否毗邻血管、肌腱或筋膜无显著关联(p=0.19)。
局限性
- 原文为回顾性研究。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To review histologic diagnoses of soft-tissue masses (STMs) ≤ 2 cm with indeterminate imaging features encountered in musculoskeletal oncology clinic at a tertiary referral center.
MATERIALS AND METHODS: This was an IRB-approved retrospective review of patients with STMs ≤ 2 cm, referred to our tertiary care orthopedic oncology clinic over 4.75 consecutive years. Maximum diameter was based on imaging measurement by a fellowship-trained musculoskeletal radiologist. Simple lipomas, synovial cysts, metastases, and cases without histologic confirmation were excluded. Patient demographics, tumor imaging features (location, depth, size, and tumor:muscle enhancement and T2 signal ratios), and histology were recorded and compared.
RESULTS: Mean maximum diameter for 42 trunk/extremity STMs was 1.5 cm (range, 0.7 to 2 cm). Mean age was 48 years (range, 18-83 years). Nine (21%) of the masses were malignant, while 33 (79%) were non-malignant. Thirty-nine (93%) of masses were superficial; 7/39 (18%) of these superficial tumors were malignant. Malignancy was not associated with underlying vessels, tendon, or fascia (p = 0.19). The non-malignant vs. malignant tumor:muscle enhancement ratio was 2.15 vs. 2.32 (p = 0.58) and enhancement coefficient of variation was 0.14 vs. 0.10 (p = 0.29). Most common malignant histologic subtypes were synovial sarcoma (n = 3), fibroblastic/myofibroblastic sarcoma (n = 2), leiomyosarcoma (n = 2), myxofibrosarcoma (n = 1), and angiomatoid fibrous histiocytoma (n = 1). The majority (67%) of non-malignant lesions were: leiomyoma (n = 6), angiomyoma (n = 5), schwannoma (n = 4), benign fibrous histiocytoma (n = 4), and hemangioma (n = 3).
CONCLUSIONS: At a tertiary musculoskeletal oncology referral clinic, primary STMs ≤ 2 cm with indeterminate imaging features should be managed cautiously despite their small size and/or superficial location.
引用
- Pham K, Ezuddin NS, Pretell-Mazzini J, et al. Small soft tissue masses indeterminate at imaging: histological diagnoses at a tertiary orthopedic oncology clinic. Skeletal Radiol. 2019. PMID: 30903259. doi:10.1007/s00256-019-03205-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。